Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, vaccines and consumer health products.
We believe this targeted portfolio best meets the challenges and opportunities in a dynamically changing healthcare environment.
The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines we provide to patients, physicians and healthcare organizations.
This business develops and markets patent-protected prescription drugs for important health needs. Our products are concentrated in major therapeutic areas:
Our current product portfolio includes more than 45 key marketed products, many of which are leaders in their respective therapeutic areas. The product development pipeline involves about 140 projects in various stages of clinical development – including potential new products as well as potential new indications or formulations for existing products.
